Yuyu Pharma Statistics
Total Valuation
Yuyu Pharma has a market cap or net worth of KRW 68.41 billion. The enterprise value is 81.53 billion.
Market Cap | 68.41B |
Enterprise Value | 81.53B |
Important Dates
The last earnings date was Wednesday, August 13, 2025.
Earnings Date | Aug 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Yuyu Pharma has 15.76 million shares outstanding. The number of shares has decreased by -4.43% in one year.
Current Share Class | 15.76M |
Shares Outstanding | 15.76M |
Shares Change (YoY) | -4.43% |
Shares Change (QoQ) | +30.06% |
Owned by Insiders (%) | 35.92% |
Owned by Institutions (%) | 0.04% |
Float | 10.10M |
Valuation Ratios
The trailing PE ratio is 17.63.
PE Ratio | 17.63 |
Forward PE | n/a |
PS Ratio | 0.51 |
PB Ratio | 0.51 |
P/TBV Ratio | 0.58 |
P/FCF Ratio | 6.09 |
P/OCF Ratio | 3.93 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.16, with an EV/FCF ratio of 7.25.
EV / Earnings | 20.64 |
EV / Sales | 0.60 |
EV / EBITDA | 5.16 |
EV / EBIT | 8.00 |
EV / FCF | 7.25 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.21.
Current Ratio | 1.66 |
Quick Ratio | 0.82 |
Debt / Equity | 0.21 |
Debt / EBITDA | 1.83 |
Debt / FCF | 2.55 |
Interest Coverage | 3.47 |
Financial Efficiency
Return on equity (ROE) is 4.78% and return on invested capital (ROIC) is 3.83%.
Return on Equity (ROE) | 4.78% |
Return on Assets (ROA) | 3.13% |
Return on Invested Capital (ROIC) | 3.83% |
Return on Capital Employed (ROCE) | 6.99% |
Revenue Per Employee | 532.75M |
Profits Per Employee | 15.55M |
Employee Count | 254 |
Asset Turnover | 0.68 |
Inventory Turnover | 1.91 |
Taxes
Income Tax | -114.58M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.78% in the last 52 weeks. The beta is 0.35, so Yuyu Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.35 |
52-Week Price Change | -10.78% |
50-Day Moving Average | 4,482.60 |
200-Day Moving Average | 4,511.78 |
Relative Strength Index (RSI) | 44.92 |
Average Volume (20 Days) | 26,272 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Yuyu Pharma had revenue of KRW 135.32 billion and earned 3.95 billion in profits. Earnings per share was 246.23.
Revenue | 135.32B |
Gross Profit | 51.45B |
Operating Income | 10.01B |
Pretax Income | 6.16B |
Net Income | 3.95B |
EBITDA | 15.64B |
EBIT | 10.01B |
Earnings Per Share (EPS) | 246.23 |
Balance Sheet
The company has 28.78 billion in cash and 28.67 billion in debt, giving a net cash position of 109.90 million or 6.97 per share.
Cash & Cash Equivalents | 28.78B |
Total Debt | 28.67B |
Net Cash | 109.90M |
Net Cash Per Share | 6.97 |
Equity (Book Value) | 134.75B |
Book Value Per Share | 7,709.34 |
Working Capital | 38.16B |
Cash Flow
In the last 12 months, operating cash flow was 17.39 billion and capital expenditures -6.15 billion, giving a free cash flow of 11.24 billion.
Operating Cash Flow | 17.39B |
Capital Expenditures | -6.15B |
Free Cash Flow | 11.24B |
FCF Per Share | 713.13 |
Margins
Gross margin is 38.02%, with operating and profit margins of 7.40% and 3.76%.
Gross Margin | 38.02% |
Operating Margin | 7.40% |
Pretax Margin | 4.55% |
Profit Margin | 3.76% |
EBITDA Margin | 11.56% |
EBIT Margin | 7.40% |
FCF Margin | 8.31% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.32%.
Dividend Per Share | 100.00 |
Dividend Yield | 2.32% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 37.86% |
Buyback Yield | 4.43% |
Shareholder Yield | 6.77% |
Earnings Yield | 5.77% |
FCF Yield | 16.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on March 30, 2021. It was a forward split with a ratio of 2.
Last Split Date | Mar 30, 2021 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Yuyu Pharma has an Altman Z-Score of 1.92 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.92 |
Piotroski F-Score | 7 |